Zoned Properties, Inc. (OTC: ZDPY) posted a loss from operations of $46,236 for the quarter ending June 30, 2026. This marks a stark decline compared to the previous year when the company recorded income from operations of $272,188, reflecting a 116.9% decrease year-over-year. While …
Sinda Ltd.’s IPO and concurrent placement generated $331.3 million in gross proceeds, instantly placing the company on a solid financial footing. The cash influx, together with the 5.0 % equity stake retained by Fresnillo, creates aCapital Structurethat can underwrite the full 60,810‑meter surface drilling …
Multiple real estateInvestmenttrusts reported earnings below analysts’ expectations, triggering a sell‑off that pushed their share prices lower across the sector, and prompting investors to reassess exposure to property‑linked equities as the market digests weakerRevenuetrends andMarginpressure.
Contango Silver & Gold Inc. (NYSE American: CTGO) recorded an operational loss of $8.5 million for the second quarter of 2026, along with a net income of $4.8 million. The company's cash position experienced a notable increase to $89 million, up from $64.8 million …
The 0.1% rise capped a week‑long gain of 1.8% and continued a month‑long ascent of 17.1%, while the metal sits 71.8% above its level a year ago. Soft economic data released earlier in the day dampened risk appetite for growth stocks, prompting a shift …
National Presto Industries Inc. (NYSE: NPK) has been awarded significant defense contracts totaling $159.1 million. The company announced these awards on August 14, 2026, resulting fromOptionsexercised in year five of a five-year agreement for 40mm systems with the U.S. Army. The awarded contracts enhance …
Union Pacific (NYSE: UNP), a prominent US railroad operator, has strategically managed its fuel cost recovery mechanisms, transforming what was initially intended as a cost offset into a source of direct profit. This unexpected development occurred against a backdrop of heightened energy price volatility, …
Zentalis Pharmaceuticals, Inc. sells 23,000,000 shares of common stock at $3.50 per share, raising approximately $75.1 million. This funding will support clinical trials, pre-commercial activities, and other corporate purposes.
Embraer’s second‑quarter performance has sparked renewed optimism across the aerospace sector, as the Brazilian aircraft maker’s shares advanced markedly amid a backdrop of strengthening airline demand. The surge has translated into elevated trading activity on major exchanges, with the sector’sindexreacting positively to the carrier’s …
TuHURA Biosciences, Inc. (NASDAQ: HURA) announced its second-quarter financial results for the period ending June 30, 2026. The company reported research and development expenses of $6.6 million, an increase from $4.9 million in the same quarter of 2025. This rise reflects a boost in …